National Institutes of Health (NIH) Director Francis Collins announced in April that his agency will be partnering with drug manufacturers to address the opioid and pain crisis. The project is known as the Helping to End Addiction Long-Term (HEAL) Initiative. Topping the list of projects (and expected to enjoy the lion's share of the funding) is the development of pain medications without addiction potential.
The answer to that dilemma is also on the list of projects: a vaccine against opioid and pain medication addiction. In addition, the NIH is looking at "the development of the nasal form of naloxone, the most commonly used nasal spray for reversing opioid overdose, the development of buprenorphine for the treatment of opioid use disorder, and evidence for the use of nondrug and mind/body techniques such as yoga, tai chi, acupuncture, and mindfulness meditation to help patients control and manage pain."1
This "public-private partnership" will be federally funded at $1.1 billion. The NIH website further explains that "NIH is working with FDA and private sector experts to identify areas of opportunity to advance pharmacological treatments for pain and addiction." The goals are as follows:
Short Term: Enhance the range of medication options to treat opioid use disorders, prevent and reverse overdoses, and support long term recovery in patients.
Longer Term: Develop new alternatives for pain relief, including safe, more effective, and non-addictive pain relievers or non-opioid analgesics.
The obvious irony is that the drug companies who created the opioid crisis are going to be given over a billion dollars from the NIH to develop drugs to solve this crisis or replace the opioids they are making huge profits on with other drugs that could earn them even more money.
Meanwhile, in a More Intelligent Part of the Universe...
In a recent JAMA interview, Robert Kerns, PhD, formerly the VA's first national program director for pain management, discussed the Pain Management Collaboratory he is heading up. The collaboratory is an initiative of the NIH's National Center for Complementary and Integrative Health (NCCIH), the Department of Defense and the Veterans Administration.2
Dr. Kerns explained that the "collaboratory is to study the effectiveness of a variety of nondrug approaches to pain management that have sufficient evidence to suggest their potential value in an integrated model of care." The budget for the effort includes $81 million that will hopefully fund 12 grants over six years, all of which are for trials investigating nondrug approaches to pain management.
According to an announcement made late last year, the focus is "on developing, implementing, and testing cost-effective, large-scale, real-world research on nondrug approaches for pain management and related conditions in military and veteran health care delivery organizations." Among those studies already awarded funding, Christine Goertz, DC, PhD, at Palmer College of Chiropractic, will be developing and implementing a pragmatic randomized trial looking at chiropractic care for low back pain in this setting, including maintenance care.3
The $81 million in research investigating non-pharma solutions to pain management is welcome indeed. But it is overshadowed by the $1.1 billion "public-private partnership" in a misplaced effort to solve the opioid/pain medication crises with more drugs. The NIH is essentially rewarding what many feel is criminal behavior on the part of the drug companies.
Chiropractic will undoubtedly once again emerge as a safe, effective first choice for most ailments. How much recognition these results get remains to be seen.
References
Read more findings on my blog: http://blog.toyourhealth.com/wrblog/. You can also visit me on Facebook.
When sports chiropractors first appeared at the Olympic Games in the 1980s, it was alongside individual athletes who had experienced the benefits of chiropractic care in their training and recovery processes at home. Fast forward to Paris 2024, where chiropractic care was available in the polyclinic for all athletes, and the attitude has now evolved to recognize that “every athlete deserves access to sports chiropractic."
It is estimated that 61% of patients with CTS avoid taking surgical options due to postoperative complications and costly surgical procedures. Chiropractic care offers a comprehensive and effective treatment for carpal tunnel syndrome, addressing the condition from multiple angles. Recent studies also have unveiled a game-changing adjunct to chiropractic treatments for CTS: nerve flossing.
Some doctors thrive in a personality-based clinic and have a loyal following no matter what services or equipment they offer, but for most chiropractic offices who are trying to grow and expand, new equipment purchases help us stay relevant and continue to service our client base in the best, most up-to-date manner possible. So, regarding equipment purchasing: should you lease, get a bank loan, or pay cash?
